Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models
Abstract Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early-onset Alzheimer’s disease, in which amyloid-β accumulates in the brain. Amyloid-β is a product of the chromosome 21 gene APP (amyloid precursor protein) and the extra copy or ‘dose...
Guardado en:
Autores principales: | Justin L. Tosh, Elena R. Rhymes, Paige Mumford, Heather T. Whittaker, Laura J. Pulford, Sue J. Noy, Karen Cleverley, LonDownS Consortium, Matthew C. Walker, Victor L. J. Tybulewicz, Rob C. Wykes, Elizabeth M. C. Fisher, Frances K. Wiseman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/976af835ad394de686b40b465f483f68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models
por: Justin L. Tosh, et al.
Publicado: (2021) -
The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
por: Yixing Wu, et al.
Publicado: (2021) -
Dissection of the amyloid formation pathway in AL amyloidosis
por: Pamina Kazman, et al.
Publicado: (2021) -
Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
por: Eric A Tanifum, et al.
Publicado: (2012) -
VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice.
por: Min Song, et al.
Publicado: (2012)